SanaCurrents on the FDA’s lifejacket to Akebia’s (AKBA) anemia drug for dialysis patients
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Probability Sentiment SUMMARY The FDA informed Akebia Therapeutics, Inc. (NASDAQ:AKBA) on [...]
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Probability Sentiment SUMMARY The FDA informed Akebia Therapeutics, Inc. (NASDAQ:AKBA) on [...]
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Probability Sentiment SUMMARY Akebia Therapeutics’ vadadustat belongs to a class of [...]